FUND 1- raising soon
Venture capital treats founder health as optional. We treat it as infrastructure.
- Longevity biotech
- ·AI-enabled biological tooling
A $10M pre-seed and seed fund. Every founder we back is coached by the partners on sleep, recovery and training from the day we wire, because operator capacity is what advances the milestones the next round is priced on.
- Target fund size
- $10M
- Deployment period
- 2 years
- Harvest period
- 8 years
- Final close
- Dec 2027
Track record: five companies backed to date -four pre-seed and seed, and one series B- all longevity-adjacent. Fund I extends the same underwriting into AI-enabled biological tooling.